X4 Pharmaceuticals (XFOR) Enterprise Value

Price: $0.19
Market Cap: $33.13M
Avg Volume: 3.32M
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 0.581
52W Range: $0.188-1.39
Website: X4 Pharmaceuticals
Enterprise Value Summary (Quarterly)

According to X4 Pharmaceuticals's latest quarterly financial reports:

  • The enterprise value (EV) is 169.89M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
  • The market capitalization is 147.50M, which is calculated by multiplying the current share price by the total number of outstanding shares.
  • The stock price is $0.7336, with 201.06M shares outstanding.
  • The company has 55.70M in cash and cash equivalents and 78.09M in total debt.

Enterprise Value (EV) Formula:

EV = Market Cap + Total Debt - Cash and Cash Equivalents

Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.

Enterprise Value

$169.89M

Market Cap

$147.50M

Total Debt

$78.09M

Cash and Equivalents

$55.70M

Historical Enterprise Value
$280.00M$280.00M$210.00M$210.00M$140.00M$140.00M$70.00M$70.00M$0.00$0.00-$70.00M-$70.00MEnterprise Value2017201720182018201920192020202020212021202220222023202320242024
X4 Pharmaceuticals Historical Enterprise Values

The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.

Date Enterprise Value EV Change (%) Stock Price Number of Shares Market Cap Cash & Equivalents Total Debt
December 31, 2024 $169.89M 47.43% $0.7336 201.06M $147.50M $55.70M $78.09M
September 30, 2024 $115.23M 134.45% $0.6693 200.87M $134.44M $97.41M $78.20M
June 30, 2024 $49.15M -82.43% $0.5894 200.44M $118.14M $147.22M $78.23M
March 31, 2024 $279.77M 122.96% $1.41 199.99M $281.99M $60.49M $58.27M
December 31, 2023 $125.48M -11.27% $0.8385 198.77M $166.67M $99.47M $58.28M
September 30, 2023 $141.42M -37.92% $1.09 196.99M $214.72M $131.58M $58.29M
June 30, 2023 $227.80M 730.30% $1.94 168.74M $327.35M $136.43M $36.87M
March 31, 2023 $27.44M -37.06% $0.87 145.97M $126.99M $136.43M $36.87M
December 31, 2022 $43.59M -51.03% $0.993 100.77M $100.06M $93.41M $36.93M
September 30, 2022 $89.01M 253.34% $1.71 100.77M $172.31M $121.72M $38.42M
June 30, 2022 $25.19M -19.84% $0.965 35.44M $34.20M $47.38M $38.37M
March 31, 2022 $31.43M 28.82% $1.75 33.74M $59.04M $66.43M $38.81M
December 31, 2021 $24.40M -76.59% $2.29 29.00M $66.40M $81.79M $39.78M
September 30, 2021 $104.21M -11.04% $5.29 26.61M $140.76M $76.39M $39.84M
June 30, 2021 $117.14M 13.15% $6.5 26.53M $172.43M $95.16M $39.88M
March 31, 2021 $103.53M 15.73% $8.61 20.75M $178.67M $114.94M $39.81M
December 31, 2020 $89.46M 14.49% $6.43 20.17M $129.72M $78.71M $38.45M
September 30, 2020 $78.13M -29.44% $6.77 20.09M $135.98M $88.81M $30.97M
June 30, 2020 $110.74M -1.96% $9.32 20.03M $186.70M $103.74M $27.78M
March 31, 2020 $112.95M 54.91% $10 20.01M $200.14M $115.05M $27.87M
December 31, 2019 $72.92M -44.70% $10.7 16.47M $176.19M $126.18M $22.91M
September 30, 2019 $131.84M -10.00% $12.71 14.56M $185.08M $76.25M $23.01M
June 30, 2019 $146.49M 367.48% $15.75 13.18M $207.54M $90.18M $29.13M
March 31, 2019 $31.34M 2878.96% $17.96 1.72M $30.86M $22.30M $22.78M
December 31, 2018 $1.05M -113.44% $13.92 1.72M $23.91M $30.75M $7.89M
September 30, 2018 $-7.83M -159.42% $9.3 2.39M $22.19M $40.75M $10.73M
June 30, 2018 $13.18M -95.21% $21.78 2.38M $51.92M $49.94M $11.19M
March 31, 2018 $275.22M 1251.52% $137.34 2.38M $327.20M $64.00M $12.02M
December 31, 2017 $20.36M -85.25% $76.56 1.11M $84.92M $76.79M $12.24M
September 30, 2017 $138.06M 136.77% $84.18 1.80M $151.80M $26.25M $12.52M
June 30, 2017 $58.31M -38.23% $84.18 928.01K $78.12M $32.50M $12.69M
March 31, 2017 $94.40M 4.45% $84.18 928.01K $78.12M $3.88M $20.15M
December 31, 2016 $90.37M 170.38% $84.18 928.01K $78.12M $3.04M $15.29M
March 31, 2016 $33.43M - $84.18 397.07K $33.43M $- $-

Related Metrics

Explore detailed financial metrics and analysis for XFOR.